Press Releases

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the Company's fourth quarter 2020 performance in a...

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at...

Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr....

Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2021, its Board of Directors has appointed Jennifer L. Honeycutt to the position of Executive Vice President of Danaher...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on January 29, 2021 to...

Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference on Tuesday, December 1, 2020 at...

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Wolfe Research Healthcare Conference on Thursday,...

Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today published its 2020 Sustainability Report, highlighting key environmental, social and governance developments at the Company and...

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended October 2, 2020. All results in this release reflect only continuing operations unless otherwise...

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2020 on Thursday, October 22, 2020 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it will redeem all of the €800,000,000 aggregate principal amount of 1.700% Senior Notes due 2022 (NYSE: DHR /22) issued by DH...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of $1,000,000,000 principal amount of 2.600% senior notes due 2050 at an offering price of 98.970% of the...

Danaher Corporation (NYSE: DHR) (the "Company") announced today a correction to the previously announced quarterly cash dividend payable on its 5.00% Series B Mandatory Convertible Preferred...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on October 30, 2020 to...

Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has implemented its previously disclosed succession plan and appointed Rainer M. Blair...

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended July 3, 2020. All results in this release reflect only continuing operations unless otherwise noted....

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2020 on Thursday, July 23, 2020 beginning at 8:00 a.m. ET and...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 9,509,203 shares of common stock at a price to the public of $163.00 per share and 1,717,500...

Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 9,509,203 shares of common stock at a price to the public of $163.00 per share and 1,550,000...

Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.25 billion of shares of common stock and $1.25 billion of shares of Series B Mandatory...

Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today announced that Executive Vice President, Rainer M. Blair, will succeed Thomas P. Joyce Jr. as President and Chief Executive...

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended April 3, 2020. All results in this release reflect only continuing operations unless otherwise noted....

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on July 31, 2020 to...

Danaher Corporation (NYSE: DHR) ("Danaher") announced today it completed the sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle...